Haemonetics Stock Price on December 13, 2024
| HAE Stock | USD 80.05 1.65 2.10% |
Below is the normalized historical share price chart for Haemonetics extending back to May 10, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Haemonetics stands at 80.05, as last reported on the 4th of January, with the highest price reaching 80.15 and the lowest price hitting 77.79 during the day.
If you're considering investing in Haemonetics Stock, it is important to understand the factors that can impact its price. At this point, Haemonetics is very steady. Haemonetics holds Efficiency (Sharpe) Ratio of 0.0365, which attests that the entity had a 0.0365% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Haemonetics, which you can use to evaluate the volatility of the firm. Please check out Haemonetics' Risk Adjusted Performance of 0.0224, downside deviation of 1.85, and Market Risk Adjusted Performance of 0.118 to validate if the risk estimate we provide is consistent with the expected return of 0.0845%.
At present, Haemonetics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 766.3 M, whereas Common Stock Total Equity is forecasted to decline to about 421 K. . At present, Haemonetics' Price To Free Cash Flows Ratio is projected to increase based on the last few years of reporting. Haemonetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of May 1991 | 200 Day MA 82.9117 | 50 Day MA 81.446 | Beta 0.321 |
Haemonetics |
Sharpe Ratio = 0.0365
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HAE | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Haemonetics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Haemonetics by adding it to a well-diversified portfolio.
Price Book 4.4803 | Enterprise Value Ebitda 17.5633 | Price Sales 2.9535 | Shares Float 49.7 M | Wall Street Target Price 110.8 |
Haemonetics Main Headline on 13th of December 2024
Blood Market to Grow by USD 2.6 Billion , Report on AI-Drive... by finance.yahoo.com
Report with the AI impact on market trends - The global blood market size is estimated to grow by USD 2.60 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.94 percent during the forecast period. Rising number of hospitals and blood banks is driving market growth, with a trend towards rising awareness about blood donation. However, low availability of blood storagetransfusion facilities in rural areas poses a challenge. Key market players include Abbott Lab
Haemonetics Valuation on December 13, 2024
It is possible to determine the worth of Haemonetics on a given historical date. On December 13, 2024 Haemonetics was worth 82.03 at the beginning of the trading date compared to the closed value of 81.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Haemonetics stock. Still, in general, we apply an absolute valuation method to find Haemonetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Haemonetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Haemonetics' related companies.
| Open | High | Low | Close | Volume | |
| 82.79 | 83.15 | 81.30 | 82.30 | 376,649 | |
12/13/2024 | 82.03 | 82.96 | 81.07 | 81.19 | 454,864 |
| 80.99 | 82.68 | 80.65 | 82.25 | 514,965 |
| Backtest Haemonetics | | | Haemonetics History | | | Haemonetics Valuation | Previous | Next |
Haemonetics Trading Date Momentum on December 13, 2024
| On December 16 2024 Haemonetics was traded for 82.25 at the closing time. Highest Haemonetics's price during the trading hours was 82.68 and the lowest price during the day was 80.65 . The net volume was 515 K. The overall trading history on the 16th of December 2024 contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 1.31% . The trading delta at closing time to current price is 7.49% . |
Haemonetics Fundamentals Correlations and Trends
By evaluating Haemonetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Haemonetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Haemonetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Haemonetics Stock history
Haemonetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Haemonetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Haemonetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Haemonetics stock prices may prove useful in developing a viable investing in Haemonetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 46.3 M | 42.5 M | |
| Net Income Applicable To Common Shares | 132.7 M | 139.3 M |
Haemonetics Quarterly Net Working Capital |
|
Haemonetics Stock Technical Analysis
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Haemonetics Period Price Range
Low | January 4, 2025
| High |
0.00 | 0.00 |
Haemonetics cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Haemonetics January 4, 2025 Market Strength
Market strength indicators help investors to evaluate how Haemonetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Haemonetics shares will generate the highest return on investment. By undertsting and applying Haemonetics stock market strength indicators, traders can identify Haemonetics entry and exit signals to maximize returns
Haemonetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Haemonetics' price direction in advance. Along with the technical and fundamental analysis of Haemonetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Haemonetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0224 | |||
| Jensen Alpha | 0.0306 | |||
| Total Risk Alpha | 2.0E-4 | |||
| Sortino Ratio | 0.012 | |||
| Treynor Ratio | 0.108 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |